Could a single injection tame the immune system in lupus?
NCT ID NCT07749651
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This early-stage trial is testing a single injection of an experimental drug called SHR-7012 in healthy adults. The main goal is to check how safe and tolerable the drug is, and how the body absorbs and processes it. The study involves about 50 participants aged 18 to 55, who will receive either the drug or a placebo. While this trial does not include people with the disease, the drug is being developed as a potential future treatment for cutaneous lupus erythematosus, a skin condition linked to an overactive immune response.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SHR-7012 injection
- What this could lead to
- If successful, this could pave the way for a new treatment option for cutaneous lupus erythematosus, a skin condition caused by an overactive immune system.
- What could go wrong
- This is an early-stage trial in healthy volunteers, so it won't show whether the drug works for the disease. The drug may cause side effects or fail to show promise in later trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS LUPUS ERYTHEMATOSUS (CLE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, 314408, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Old malaria drug may tame lupus skin flares
- Largest skin lupus database aims to uncover disease patterns
- New drug S-4321 aims to tame overactive immune system
- New pill could tame skin lupus flares
- 10,000 lupus patients needed for landmark online study
- Lupus skin drug trial halted early – what we know